Jacqueline Cloos
Jacqueline Cloos
Research coordinator Pediatric Oncology/Hematology and Hematology, VU University Medical Center, Amsterdam
Geverifieerd e-mailadres voor vumc.nl
Titel
Geciteerd door
Geciteerd door
Jaar
Cell sensitivity assays: the MTT assay
J Van Meerloo, GJL Kaspers, J Cloos
Cancer cell culture, 237-245, 2011
14292011
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), e3088, 2008
7132008
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood 131 (12), 1275-1291, 2018
4702018
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
R Oerlemans, NE Franke, YG Assaraf, J Cloos, I van Zantwijk, CR Berkers, ...
Blood 112 (6), 2489-2499, 2008
4542008
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on …
D Averbuch, C Orasch, C Cordonnier, DM Livermore, M Mikulska, ...
haematologica 98 (12), 1826, 2013
3732013
Molecular minimal residual disease in acute myeloid leukemia
M Jongen-Lavrencic, T Grob, D Hanekamp, FG Kavelaars, A Al Hinai, ...
New England Journal of Medicine 378 (13), 1189-1199, 2018
3632018
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
K De Keersmaecker, ZK Atak, N Li, C Vicente, S Patchett, T Girardi, ...
Nature genetics 45 (2), 186-190, 2013
3542013
Molecular signature associated with bone marrow micrometastasis in human breast cancer
U Woelfle, J Cloos, G Sauter, L Riethdorf, F Jänicke, P Van Diest, ...
Cancer research 63 (18), 5679-5684, 2003
2662003
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
M Smits, J Nilsson, SE Mir, PM van der Stoop, E Hulleman, JM Niers, ...
Oncotarget 1 (8), 710, 2010
2502010
In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma
SE Mir, PCDW Hamer, PM Krawczyk, L Balaj, A Claes, JM Niers, ...
Cancer cell 18 (3), 244-257, 2010
2322010
Genetic susceptibility to head and neck squamous cell carcinoma
J Cloos, MR Spitz, SP Schantz, TC Hsu, Z Zhang, H Tobi, BJM Braakhuis, ...
JNCI: Journal of the National Cancer Institute 88 (8), 530-535, 1996
2061996
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
J Cloos, BF Goemans, CJ Hess, JW Van Oostveen, Q Waisfisz, S Corthals, ...
Leukemia 20 (7), 1217-1220, 2006
1772006
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells
NE Franke, D Niewerth, YG Assaraf, J van Meerloo, K Vojtekova, ...
Leukemia 26 (4), 757-768, 2012
1692012
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
IHIM Hollink, CM Zwaan, M Zimmermann, T Arentsen-Peters, R Pieters, ...
Leukemia 23 (2), 262-270, 2009
1672009
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
I Hubeek, RW Stam, GJ Peters, R Broekhuizen, JPP Meijerink, ...
British journal of cancer 93 (12), 1388-1394, 2005
1622005
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia
ZK Atak, V Gianfelici, G Hulselmans, K De Keersmaecker, AG Devasia, ...
PLoS Genet 9 (12), e1003997, 2013
1392013
Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes
J Cloos, EJC Nieuwenhuis, DI Boomsma, DJ Kuik, MLT Van Der Sterre, ...
Journal of the National Cancer Institute 91 (13), 1125-1130, 1999
1381999
Molecular basis of resistance to proteasome inhibitors in hematological malignancies
D Niewerth, G Jansen, YG Assaraf, S Zweegman, GJL Kaspers, J Cloos
Drug resistance updates 18, 18-35, 2015
1302015
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia
BV Balgobind, IHIM Hollink, ST Arentsen-Peters, M Zimmermann, ...
haematologica 96 (10), 1478, 2011
1222011
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2
M Smits, SE Mir, RJA Nilsson, PM van der Stoop, JM Niers, VE Marquez, ...
PloS one 6 (1), e16282, 2011
1142011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20